Board of Directors

 

Board of Directors

William W. Crouse
Mr. Crouse is a Retired Partner of HealthCare Ventures LLC, one of the world's largest biotech venture capital firms. Mr. Crouse was formerly Worldwide President of Ortho Diagnostic Systems and Vice President of Johnson & Johnson International. He also served as Division Director of DuPont Pharmaceuticals and as President of Revlon Health Care Group's companies in Latin America, Canada, and Asia/Pacific. Currently, Mr. Crouse serves as a Director of The Medicines Company as well as Director of several private biotechnology companies. Mr. Crouse formerly served as a Director of ImClone Systems, Dendreon Corporation, and Human Genome Sciences. Mr. Crouse currently serves as Trustee of the New York Blood Center.

Scott E. Deeter
Mr. Deeter is Ventria's President and CEO. He serves as a director of Iteris, Inc. (NASDAQ: ITI), the global leader in applied informatics for transportation and agriculture. Previously, he started and led a joint venture between Cargill and F. Hoffmann-La Roche that commercialized pharmaceutical intermediates and functional food ingredients. He served as President and CEO of CyberCrop and was a member of the Technology and Life Sciences Group of Salomon Brothers. He is a graduate of the University of Kansas (BSc-Economics); University of Chicago (MBA); and London School of Economics (MSc-Economics).

William H. Rutter, Esq.,
Mr. Rutter is an entrepreneur who has successfully developed a series of companies in diverse businesses including oil and gas, beverages, restaurants, and brew pubs. He formerly practiced law with the Denver, Colorado firm of Sherman & Howard. He also is president of Moab Music Festival, Inc. a 501(c)(3) charitable organization that produces a chamber music festival each year in Moab, Utah.

William J. Rutter, PhD
Dr. Rutter is Chairman and CEO of Synergenics, LLC, a consortium of seven companies which receive financial support, legal, and strategic scientific and business advice and services; these companies share technology outside their IP domains. Previously, Rutter cofounded Chiron Corporation in 1981 and served as its executive chairman until 1999. Previously Rutter was at UCSF, where he served as chairman of the Department of Biochemistry, 1969-1982, and head of the Hormone Research Institute, 1982-1989. His lab is recognized for contributions to development of recombinant DNA technologies and some of its early achievements, including the cloning of the insulin gene and the development of a vaccine for hepatitis B. He and colleagues have 381 publications and 21 patents and patent applications. He is a member of the U.S. National Academy of Sciences and the American Academy of Arts and Sciences. He has received numerous honors including the Heinz Award; the Bower Award and Prize for Achievement in Science from the Franklin Institute; and the Biotechnology Heritage Award, given jointly by the Chemical Heritage Foundation and the Biotechnology Industry Organization.

Thomas N. Urban, Jr.
Mr. Urban served as the Chairman and CEO of Pioneer Hi-Bred International Inc. from 1984 to 1996 and was its President from 1979 through 1996. He was a Visiting Professor of Harvard University's Graduate School of Business from 1995 to 1997. He served as a Board Member of Sigma-Aldrich Corporation from 1990 to 2001 and Case Corporation from 1995 to 1998. Mr. Urban is a board member and previously served as Chairman of the Carnegie Institution of Washington and served on the Board of Trustees for the National Academy of Sciences Board on Agriculture. He is a board member of the National Tropical Botanic Garden and served as Chairman from 2005 to 2009. He serves on private company boards including Intoximeters and Reach Systems. Mr. Urban served as Mayor of the City of Des Moines, Iowa, from 1968 to 1971.

Pablo Valenzuela, Ph.D.
Dr. Pablo D. T. Valenzuela is Chairman of Andes Biotechnologies S.A. and GrupoBios S.A., both leading biotechnology companies in Chile. He was a cofounder of the Chiron Corporation and was Vice President of R&D. At that time, he led a group responsible for developing the vaccine for hepatitis B, the world's first recombinant vaccine. Also, under his direction, scientists cloned and sequenced the genome of HIV, discovered the virus for hepatitis C, and developed a robust production system for several recombinant proteins. In 1997, he cofounded with Bernardita Méndez the Fundación Ciencia Para La Vida, a nonprofit research institute based in Santiago, Chile. Research at the Fundación focuses on the development of new biotechnologies for the Chilean export industry, as well as novel applications in human health.